Form 4: Bausch & Lomb Executive Andrew J. Stewart Reports Stock Transaction
SEC Form 4 Filing
Andrew J. Stewart, President, Global Pharmaceuticals and International Consumer at Bausch & Lomb Corp, reports disposition of shares to cover tax obligations upon vesting of restricted share units.
Summary
- On April 24, 2024, Andrew J. Stewart, an officer of Bausch & Lomb Corp, reported a transaction involving the disposition of 3,943 common shares.
- The shares were disposed of to satisfy tax withholding obligations related to the vesting of restricted share units.
- Following the transaction, Stewart directly owns 45,985 common shares of Bausch & Lomb Corp.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction related to tax obligations. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track the buying and selling activities of those with privileged information.
Key Dates
| Date | Description |
|---|---|
| 04/24/2024 | Date of the stock transaction (disposition of shares). |
| 04/26/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.